Cargando…
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
BACKGROUND: Previous studies of drug trials submitted to regulatory authorities have documented selective reporting of both entire trials and favorable results. The objective of this study is to determine the publication rate of efficacy trials submitted to the Food and Drug Administration (FDA) in...
Autores principales: | Rising, Kristin, Bacchetti, Peter, Bero, Lisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586350/ https://www.ncbi.nlm.nih.gov/pubmed/19067477 http://dx.doi.org/10.1371/journal.pmed.0050217 |
Ejemplares similares
-
Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
por: Rising, Kristin, et al.
Publicado: (2009) -
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
por: Bero, Lisa, et al.
Publicado: (2007) -
Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018) -
Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018
por: Cook, Jack, et al.
Publicado: (2020) -
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
por: Stone, Marc, et al.
Publicado: (2009)